Pharmacy society has a hard time when returning Chinese ‘Valsaltan’ ingredients
In a process of exchanging drugs containing Valsartan ingredients with carcinogenic factors, pharmacies are having trouble with patients over calculating patient-sharing expenses.
According to the pharmacy society, because the government took an action to suspend sales and restrict prescription ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.